News and resources from the financial markets, real estate and alternative investments. But never advice on anything, financial or personal. That's on you!
GeoVax Labs, Inc. (GOVX-NASDAQ) is progressing several clinical trials, crucial for patients with compromised immune systems and those suffering from head and neck cancers. Comprehensive 17-page Research Update now available. https://t.co/oPiXJCNN9s.
Registration Is Now Open for Tribe Public’s Webinar Event
"Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO. https://t.co/P0xv2w71qk #mpox#vaccine $GOVX
Have a question about the state of an #Mpoxvaccine ? $GOVX GeoVax Labs to Present at the Emerging Growth Conference on August 21, 2024
[email protected]
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, will present at the 36th Annual Roth Conference in Dana Point, CA, on March 17-19, 2024. https://t.co/4MRJK9MBxC
Innovators & Investors Come Together to Shape the Future of Healthcare. #biotech, #demy-colton, #innovators, #disruptors Learn more and register here. https://t.co/rm5vkU8rI8